Skip to main content

ASCIA News

  • ASCIA Action Plans for Anaphylaxis - 2025 versions
    ASCIA has developed 2025 versions of red ASCIA Action Plans for Anaphylaxis and orange ASCIA First Aid Plans for Anaphylaxis in response to recent changes reagrding adrenaline (epinephrine) devices: Anapen® 150 and Anapen® 300 are no longer available in Australia, so only...
  • National Allergy Council projects allocated to ASCIA - November 2024 Update
    Implementation of National Allergy Council Schools/Childcare projects allocated to ASCIA (funded by the Australian government) including the following achievements in 2024:  Evaluation reports based on feedback surveys in ASCIA anaphylaxis e-training courses for schools,...
  • ASCIA 2025 Conference Sponsorship Prospectus
    ASCIA supporters are invited to participate as a sponsor in the ASCIA 2025 Conference, which will be held at the Brisbane Convention and Exhibition Centre from Tuesday 2nd to Friday 5th September 2025. Please refer to the ASCIA 2025 Conference Sponsorship Prospectus for...
  • Global Collaborative Online Allergy Symposium  - 17 January 2025
    The British Society for Allergy and Clinical Immunology (BSACI), are hosting the third Global Collaborative Online Allergy Symposium which takes place on Friday 17th January 2025 at 08:00 – 18:10 GMT and ASCIA members are invited to participate. The Global Collaboration...
  • ASCIA Participation in Medical Conferences 2024
    ASCIA’s role in the National Allergy Council Shared Care for Allergy project is to facilitate anaphylaxis and allergy education and training for health professionals, and to promote patient/carer support organisations. This is being achieved in several ways, including: Development...
  • Research Opportunity: Allergic Rhinitis QUT Survey - Responses due 30 November 2024
    Identifying the main concerns of people living with allergic rhinitis (hay fever) will help set priorities for future research. Allergic rhinitis is usually caused by allergy to pollens, dust mites or furry animals, and symptoms include an itchy nose, watery eyes, sneezing or...
  • CHOICE Allergen Immunotherapy study
    CHOICE study coordinators are looking for clinicians to join them in an international multi-centre academic project, which looks at factors that drive the prescription of allergen immunotherapy in real-life clinical settings. Study title: CHOICE = “Criteria Used by Health...
  • ASCIA Highlights 2023-2024
    An ASCIA Report on Highlights 2023-2024 is on the ASCIA website https://www.allergy.org.au/about-ascia/highlights This three page Report comprises: General highlights, including "More than 3 million annual pageviews (~250.000 per month) of the ASCIA website"*  Ten year...
ASCIA Member Login

Site last updated: 8 Nov 2024
 

ASCIA Update

Information for the community about allergic diseases, immunodeficiencies and other immune diseases.

Join our mailing list or see latest edition here...